JP2014506900A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014506900A5 JP2014506900A5 JP2013555798A JP2013555798A JP2014506900A5 JP 2014506900 A5 JP2014506900 A5 JP 2014506900A5 JP 2013555798 A JP2013555798 A JP 2013555798A JP 2013555798 A JP2013555798 A JP 2013555798A JP 2014506900 A5 JP2014506900 A5 JP 2014506900A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- tapentadol
- criteria
- hcl
- result
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KWTWDQCKEHXFFR-SMDDNHRTSA-N tapentadol Chemical compound CN(C)C[C@H](C)[C@@H](CC)C1=CC=CC(O)=C1 KWTWDQCKEHXFFR-SMDDNHRTSA-N 0.000 description 5
- 229960005126 tapentadol Drugs 0.000 description 5
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161449329P | 2011-03-04 | 2011-03-04 | |
| US61/449,329 | 2011-03-04 | ||
| EP11003603.5 | 2011-05-03 | ||
| EP11003603 | 2011-05-03 | ||
| PCT/EP2012/000906 WO2012119729A1 (en) | 2011-03-04 | 2012-03-02 | Semisolid aqueous pharmaceutical composition containing tapentadol |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016200663A Division JP6259042B2 (ja) | 2011-03-04 | 2016-10-12 | タペンタドールを含む半固形の水性医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014506900A JP2014506900A (ja) | 2014-03-20 |
| JP2014506900A5 true JP2014506900A5 (enExample) | 2016-09-01 |
| JP6027549B2 JP6027549B2 (ja) | 2016-11-16 |
Family
ID=44652117
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013555798A Expired - Fee Related JP6027549B2 (ja) | 2011-03-04 | 2012-03-02 | タペンタドールを含む半固形の水性医薬組成物 |
| JP2016200663A Expired - Fee Related JP6259042B2 (ja) | 2011-03-04 | 2016-10-12 | タペンタドールを含む半固形の水性医薬組成物 |
| JP2017228602A Expired - Fee Related JP6670283B2 (ja) | 2011-03-04 | 2017-11-29 | タペンタドールを含む半固形の水性医薬組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016200663A Expired - Fee Related JP6259042B2 (ja) | 2011-03-04 | 2016-10-12 | タペンタドールを含む半固形の水性医薬組成物 |
| JP2017228602A Expired - Fee Related JP6670283B2 (ja) | 2011-03-04 | 2017-11-29 | タペンタドールを含む半固形の水性医薬組成物 |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US9446008B2 (enExample) |
| EP (3) | EP2680834B1 (enExample) |
| JP (3) | JP6027549B2 (enExample) |
| KR (2) | KR101911362B1 (enExample) |
| CN (1) | CN103501774A (enExample) |
| AU (2) | AU2012224954C1 (enExample) |
| BR (1) | BR112013022556A8 (enExample) |
| CA (1) | CA2828637C (enExample) |
| CY (1) | CY1119725T1 (enExample) |
| DK (1) | DK2680834T3 (enExample) |
| EA (2) | EA025194B1 (enExample) |
| ES (2) | ES2910085T3 (enExample) |
| HR (1) | HRP20171836T1 (enExample) |
| HU (1) | HUE037491T2 (enExample) |
| IL (2) | IL227826B (enExample) |
| LT (1) | LT2680834T (enExample) |
| MX (2) | MX344473B (enExample) |
| NO (1) | NO2680834T3 (enExample) |
| PL (1) | PL2680834T3 (enExample) |
| PT (2) | PT2680834T (enExample) |
| RS (1) | RS56692B1 (enExample) |
| SI (1) | SI2680834T1 (enExample) |
| WO (1) | WO2012119729A1 (enExample) |
| ZA (1) | ZA201306480B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX369121B (es) | 2011-03-04 | 2019-10-30 | Gruenenthal Gmbh | Formulacion farmaceutica acuosa de tapentadol para administracion oral. |
| US9446008B2 (en) * | 2011-03-04 | 2016-09-20 | Gruenenthal Gmbh | Semisolid aqueous pharmaceutical composition containing tapentadol |
| US8997860B2 (en) | 2011-08-05 | 2015-04-07 | Halliburton Energy Services, Inc. | Methods for monitoring the formation and transport of a fracturing fluid using opticoanalytical devices |
| US9395306B2 (en) | 2011-08-05 | 2016-07-19 | Halliburton Energy Services, Inc. | Methods for monitoring fluids within or produced from a subterranean formation during acidizing operations using opticoanalytical devices |
| US8619256B1 (en) | 2012-09-14 | 2013-12-31 | Halliburton Energy Services, Inc. | Systems and methods for monitoring the properties of a fluid cement composition in a flow path |
| US20140076550A1 (en) | 2012-09-14 | 2014-03-20 | Halliburton Energy Services, Inc. | Systems and Methods for Detecting Microannulus Formation and Remediation |
| US9228940B2 (en) | 2012-09-14 | 2016-01-05 | Halliburton Energy Services, Inc. | Systems, methods, and apparatuses for in situ monitoring of cement fluid compositions and setting processes thereof |
| US20160136112A1 (en) * | 2013-08-02 | 2016-05-19 | Ratiopharm Gmbh | Composition comprising tapentadol in a dissolved form |
| EP2845625A1 (en) | 2013-09-04 | 2015-03-11 | Grünenthal GmbH | Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome |
| TW201642843A (zh) * | 2015-03-27 | 2016-12-16 | 歌林達有限公司 | 他噴他多腸胃外給藥的穩定製劑 |
| EP3515412B1 (en) | 2016-09-23 | 2025-04-23 | Grünenthal GmbH | Stable formulation for parenteral administration of tapentadol |
| JP2021532112A (ja) * | 2018-07-24 | 2021-11-25 | ドクトア・アウグスト・ボルフ・ゲーエムベーハー・ウント・コンパニー・カー・ゲー−アルツナイミツテル | 抗コリン性化合物の局所用エマルション |
| EP3846852A4 (en) | 2018-09-07 | 2022-06-15 | R.P. Scherer Technologies, LLC | Solid or semisolid lipid based dosage form stabilization through curing and addition of low hlb surfactant(s) |
| CA3128882A1 (en) | 2019-03-18 | 2020-09-24 | Sunstar Americas, Inc. | Oral care composition |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4775678A (en) * | 1984-10-01 | 1988-10-04 | Schering Corporation | Clotrimazole cream |
| DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| US6183758B1 (en) * | 1998-01-29 | 2001-02-06 | Highland Laboratories, Inc. | Phytochemicals, nutrients & medication absorption &/or treatment |
| US6399087B1 (en) | 2000-12-20 | 2002-06-04 | Amphastar Pharmaceuticals, Inc. | Propofol formulation with enhanced microbial inhibition |
| DE10109763A1 (de) | 2001-02-28 | 2002-09-05 | Gruenenthal Gmbh | Pharmazeutische Salze |
| US20050176790A1 (en) * | 2001-02-28 | 2005-08-11 | Johannes Bartholomaus | Pharmaceutical salts |
| PE20030527A1 (es) | 2001-10-24 | 2003-07-26 | Gruenenthal Chemie | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen |
| CA2479350A1 (en) | 2002-03-15 | 2003-09-25 | Cypress Bioscience, Inc. | Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes |
| US20030191187A1 (en) | 2002-04-01 | 2003-10-09 | Lee Fang Yu | Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same |
| EP1545477A4 (en) | 2002-09-13 | 2006-11-22 | Cydex Inc | CAPSULES CONTAINING AQUEOUS FILLING COMPOSITIONS STABILIZED WITH DERIVED CYCLODEXTRIN |
| US20040180915A1 (en) | 2003-03-14 | 2004-09-16 | Xanodyne Pharmacal, Inc. | Methadone-containing compositions for parenteral administration and method of use thereof |
| US20060111382A1 (en) | 2004-05-17 | 2006-05-25 | Pharmacofore, Inc. | Compositions and methods for treating or preventing pain |
| DK1612203T3 (da) | 2004-06-28 | 2007-12-03 | Gruenenthal Gmbh | Krystallinske former af (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenolhydrochlorid |
| AR053304A1 (es) | 2004-07-01 | 2007-05-02 | Gruenenthal Gmbh | Formas farmaceuticas orales protegidas frente al abuso con liberacion controlada de (1r,2r)-3-(3 dimetilamino-1-etil-2metil-propil)fenol y procedimiento para su produccion. |
| MX2007013583A (es) | 2005-04-28 | 2008-03-13 | Theraquest Biosciences Llc | Metodos y composiciones para tratar el dolor. |
| TWI329334B (en) | 2005-12-02 | 2010-08-21 | Chung Shan Inst Of Science | Manufacture method of electromagnetic interference layer for the plasma display panel |
| WO2007127158A2 (en) * | 2006-04-25 | 2007-11-08 | Croda, Inc | Modification of percutaneous absorption of topically active materials |
| HRP20110271T1 (hr) | 2006-04-28 | 2011-05-31 | Grnenthal Gmbh | Farmaceutska kombinacija koja sadrži 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i nsaid (nesteroidni antiinflamatorni lijek) |
| CN101431990B (zh) | 2006-04-28 | 2011-08-03 | 格吕伦塔尔有限公司 | 包含3-（3-二甲基氨基-1-乙基-2-甲基-丙基）-酚和对乙酰氨基酚的药物结合 |
| MX2009000911A (es) | 2006-07-24 | 2009-02-04 | Janssen Pharmaceutica Nv | Preparacion de (2r,3r)-3-(3-metoxifenil)-n,n,2-trimetilpentanamina . |
| DE102007012165A1 (de) | 2007-03-12 | 2008-09-18 | Grünenthal GmbH | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes |
| EP1985292A1 (en) | 2007-04-23 | 2008-10-29 | Grünenthal GmbH | Titration of tapentadol |
| EP2219633A2 (en) * | 2007-11-23 | 2010-08-25 | Nectid, Inc. | Tapentadol compositions |
| CA2713128C (en) | 2008-01-25 | 2016-04-05 | Gruenenthal Gmbh | Pharmaceutical dosage form |
| ES2758831T3 (es) * | 2008-10-30 | 2020-05-06 | Gruenenthal Gmbh | Nuevas y potentes formas de dosificación de tapentadol |
| US20100227921A1 (en) | 2009-03-03 | 2010-09-09 | Shire Llc | Amino acid and peptide carbamate prodrugs of tapentadol and uses thereof |
| US20100272815A1 (en) | 2009-04-28 | 2010-10-28 | Actavis Group Ptc Ehf | Amorphous form of tapentadol hydrochloride |
| US20110190267A1 (en) * | 2010-01-05 | 2011-08-04 | Shire Pharmaceuticals, Inc. | Prodrugs of opioids and uses thereof |
| JP5806287B2 (ja) * | 2010-03-30 | 2015-11-10 | フォスファジェニクス リミティド | 経皮送達パッチ |
| GB201006200D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| US20120270848A1 (en) * | 2010-10-22 | 2012-10-25 | Galleon Pharmaceuticals, Inc. | Novel Compositions and Therapeutic Methods Using Same |
| US9446008B2 (en) * | 2011-03-04 | 2016-09-20 | Gruenenthal Gmbh | Semisolid aqueous pharmaceutical composition containing tapentadol |
-
2012
- 2012-03-02 US US13/410,837 patent/US9446008B2/en active Active
- 2012-03-02 MX MX2013010100A patent/MX344473B/es active IP Right Grant
- 2012-03-02 LT LTEP12710026.1T patent/LT2680834T/lt unknown
- 2012-03-02 DK DK12710026.1T patent/DK2680834T3/en active
- 2012-03-02 RS RS20171334A patent/RS56692B1/sr unknown
- 2012-03-02 KR KR1020137026185A patent/KR101911362B1/ko not_active Expired - Fee Related
- 2012-03-02 KR KR1020187029861A patent/KR102039320B1/ko not_active Expired - Fee Related
- 2012-03-02 HU HUE12710026A patent/HUE037491T2/hu unknown
- 2012-03-02 HR HRP20171836TT patent/HRP20171836T1/hr unknown
- 2012-03-02 JP JP2013555798A patent/JP6027549B2/ja not_active Expired - Fee Related
- 2012-03-02 CN CN201280011678.9A patent/CN103501774A/zh active Pending
- 2012-03-02 NO NO12710026A patent/NO2680834T3/no unknown
- 2012-03-02 ES ES20188822T patent/ES2910085T3/es active Active
- 2012-03-02 PT PT127100261T patent/PT2680834T/pt unknown
- 2012-03-02 EP EP12710026.1A patent/EP2680834B1/en active Active
- 2012-03-02 EA EA201300988A patent/EA025194B1/ru not_active IP Right Cessation
- 2012-03-02 SI SI201231143T patent/SI2680834T1/en unknown
- 2012-03-02 PT PT201888229T patent/PT3766489T/pt unknown
- 2012-03-02 CA CA2828637A patent/CA2828637C/en not_active Expired - Fee Related
- 2012-03-02 ES ES12710026.1T patent/ES2654407T3/es active Active
- 2012-03-02 MX MX2016016703A patent/MX374468B/es unknown
- 2012-03-02 BR BR112013022556A patent/BR112013022556A8/pt not_active Application Discontinuation
- 2012-03-02 EP EP20188822.9A patent/EP3766489B1/en active Active
- 2012-03-02 PL PL12710026T patent/PL2680834T3/pl unknown
- 2012-03-02 EP EP17189139.3A patent/EP3290029B1/en not_active Not-in-force
- 2012-03-02 AU AU2012224954A patent/AU2012224954C1/en not_active Ceased
- 2012-03-02 EA EA201600442A patent/EA033171B1/ru not_active IP Right Cessation
- 2012-03-02 WO PCT/EP2012/000906 patent/WO2012119729A1/en not_active Ceased
-
2013
- 2013-08-06 IL IL227826A patent/IL227826B/en active IP Right Grant
- 2013-08-28 ZA ZA2013/06480A patent/ZA201306480B/en unknown
-
2016
- 2016-08-10 US US15/232,841 patent/US20160346229A1/en not_active Abandoned
- 2016-10-12 JP JP2016200663A patent/JP6259042B2/ja not_active Expired - Fee Related
-
2017
- 2017-01-04 AU AU2017200040A patent/AU2017200040B2/en not_active Ceased
- 2017-11-29 JP JP2017228602A patent/JP6670283B2/ja not_active Expired - Fee Related
-
2018
- 2018-01-03 CY CY20181100006T patent/CY1119725T1/el unknown
- 2018-01-10 US US15/867,330 patent/US20180133174A1/en not_active Abandoned
- 2018-03-26 IL IL258357A patent/IL258357A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ712270A (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| MY179756A (en) | Stabilized efinaconazole formulations | |
| PE20140591A1 (es) | Uso de una composicion que comprende un peptido antimicrobiano como un conservador de alimentos | |
| RU2015141767A (ru) | Композиции и способы для местной доставки простагландинов в подкожный жир | |
| WO2015085070A3 (en) | Liquid-fertilized ready formulations of bifenthrin | |
| WO2014182566A3 (en) | Preservation system for nutritional substances | |
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| WO2016142224A8 (en) | Fungicidal mixtures comprising strobilurin-type fungicides | |
| WO2015171460A3 (en) | Formulations of cyclophosphamide liquid concentrate | |
| WO2015003082A3 (en) | Volatile organic compound formulations having antimicrobial activity | |
| EP2692723A8 (en) | Aryloxy dihalopropenyl ether compound and use thereof | |
| MX2016000136A (es) | Mezclas conservantes sinergicas. | |
| WO2014169003A3 (en) | Multi-functional composition for cosmetic formulations | |
| EA201792144A1 (ru) | Стабильный препарат для парентерального введения тапентадола | |
| WO2017069820A3 (en) | Antimicrobial composition having efficacy against endospores | |
| WO2015198265A3 (en) | Disinfectant and antimicrobial compositions, in particular for the veterinary field | |
| WO2012131117A8 (es) | Utilización de antifúngicos naturales para prevenir la infección de lesiones, injertos y heridas de poda en plantas leñosas por hongos fitopatógenos | |
| JP2017531030A5 (enExample) | ||
| MX2015011118A (es) | Extracto de cafe que contiene acido protocatecuico y su uso en agroquimica contra patogenos de plantas. | |
| RU2010146997A (ru) | Фармацевтическая композиция, содержащая силденафил и/или алпростадил, миноксидил и/или эуфиллин, тестостерон и/или йохимбин и липосомы для местного применения | |
| PH12013502250A1 (en) | Construction material preservative | |
| CN105682672A8 (zh) | 含有来自毛泡桐的香叶基黄酮作为有效成分的用于抑制神经氨酸酶活性的组合物 | |
| JP2018070453A5 (enExample) | ||
| WO2012169860A3 (ko) | 콩 추출물을 포함하는 탈모 방지 또는 육모 촉진용 조성물 | |
| WO2014137231A3 (en) | Totarol extract formulations and uses thereof |